Northwestern Mutual Wealth Management
BCRX icon

Northwestern Mutual Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.6K Buy
7,312
+1,185
+19% +$9.2K ﹤0.01% 2321
2025
Q4 		$47.8K Sell
6,127
-1
-0% -$7 ﹤0.01% 2414
2025
Q3 		$46.5K Buy
6,128
+1
+0% +$8 ﹤0.01% 2354
2025
Q2 		$54.9K Hold
6,127
– – ﹤0.01% 2221
2025
Q1 		$46K Sell
6,127
-2,740
-31% -$22.1K ﹤0.01% 2205
2024
Q4 		$66.7K Buy
8,867
+8,340
+1,583% +$63.3K ﹤0.01% 2068
2024
Q3 		$4K Buy
+527
New +$4.01K ﹤0.01% 2961
2022
Q3 		– Sell
-1,453
Closed -$15K – 3118
2022
Q2 		$15K Buy
+1,453
New +$15K ﹤0.01% 2365
2021
Q2 		– Sell
-1,267
Closed -$13K – 2999
2021
Q1 		$13K Buy
+1,267
New +$13.1K ﹤0.01% 2204

Other funds holding BCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return